Table 2.
Complete cancer prevalence (cases, proportion per 100 000, percentage of all prevalent cases, and annual variation) by cancer typea and sex in Italy, 2030
| Cancer type | Cases |
Proportion per 100 000 |
Percentage of all prevalent cases |
Annual variation 2018-2030 (%) |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Men | Women | All | Men | Women | All | Men | Women | Cases | Proportions | |
| Alltypesbut skinnon-melanoma | 4 012 376 | 1 759 260 | 2 253 116 | 6923 | 6196 | 7621 | 100 | 100 | 100 | 1.5 | 1.8 |
| Breast | 1 053 633 | 1 053 633 | 3564 | 3564 | 26.3 | 46.8 | 2.2 | 2.6 | |||
| Prostate | 559 903 | 559 903 | 1972 | 1972 | 14.0 | 31.8 | 0.0 | 2.3 | 2.5 | ||
| Colon–rectum | 469 257 | 238 751 | 230 506 | 810 | 841 | 780 | 11.7 | 13.6 | 10.2 | 0.9 | 1.2 |
| Bladder | 320 458 | 249 892 | 70 566 | 553 | 880 | 239 | 8.0 | 14.2 | 3.1 | 1.0 | 1.3 |
| Thyroid | 280 787 | 65 961 | 214 826 | 484 | 232 | 727 | 7.0 | 3.7 | 9.5 | 3.1 | 3.4 |
| Skin melanoma | 270 175 | 132 158 | 138 017 | 466 | 465 | 467 | 6.7 | 7.5 | 6.1 | 3.6 | 3.9 |
| Non-Hodgkin’s lymphoma | 189 876 | 98 269 | 91 607 | 328 | 346 | 310 | 4.7 | 5.6 | 4.1 | 2.2 | 2.5 |
| Kidney | 174 689 | 114 706 | 59 983 | 301 | 404 | 203 | 4.4 | 6.5 | 2.7 | 2.0 | 2.3 |
| Corpus uteri | 147 560 | 147 560 | 499 | 499 | 3.7 | 6.5 | 1.6 | 2.0 | |||
| Lung | 117 956 | 61 765 | 56 191 | 204 | 218 | 190 | 2.9 | 3.5 | 2.5 | 1.2 | 1.5 |
| Leukaemia | 88 769 | 49 149 | 39 620 | 153 | 173 | 134 | 2.2 | 2.8 | 1.8 | 0.1 | 0.4 |
| Testis | 69 043 | 69 043 | 243 | 243 | 1.7 | 3.9 | 0.0 | 2.0 | 2.2 | ||
| Hodgkin’s lymphoma | 67 900 | 33 561 | 34 339 | 117 | 118 | 116 | 1.7 | 1.9 | 1.5 | 1.5 | 1.8 |
| Oral cavity | 66 946 | 40 682 | 26 264 | 116 | 143 | 89 | 1.7 | 2.3 | 1.2 | 1.9 | 2.2 |
| Stomach | 65 004 | 36 277 | 28 727 | 112 | 128 | 97 | 1.6 | 2.1 | 1.3 | −1.8 | −1.5 |
| Soft-tissue sarcoma | 55 174 | 23 263 | 31 911 | 95 | 82 | 108 | 1.4 | 1.3 | 1.4 | 0.7 | 1.0 |
| Ovary | 53 075 | 53 075 | 180 | 180 | 1.3 | 2.4 | 0.1 | 0.4 | |||
| Cervix uteri | 46 332 | 46 332 | 157 | 157 | 1.2 | 2.1 | −1.1 | −0.8 | |||
| Larynx | 36 908 | 31 178 | 5730 | 64 | 110 | 19 | 0.9 | 1.8 | 0.3 | −2.3 | −2.1 |
| Multiple myeloma | 36 817 | 19 303 | 17 514 | 64 | 68 | 59 | 0.9 | 1.1 | 0.8 | 1.2 | 1.5 |
| Brain and central nervous system | 35 995 | 21 813 | 14 182 | 62 | 77 | 48 | 0.9 | 1.2 | 0.6 | −0.3 | 0.0 |
| Pancreas | 29 164 | 14 778 | 14 386 | 50 | 52 | 49 | 0.7 | 0.8 | 0.6 | 3.7 | 4.0 |
| Liver | 28 699 | 21 535 | 7164 | 50 | 76 | 24 | 0.7 | 1.2 | 0.3 | −0.9 | −0.6 |
| Bone | 16 088 | 8216 | 7872 | 28 | 29 | 27 | 0.4 | 0.5 | 0.3 | 1.4 | 1.7 |
| Small intestine | 13 528 | 7676 | 5852 | 23 | 27 | 20 | 0.3 | 0.4 | 0.3 | 3.1 | 3.4 |
| Vagina and vulva | 12 587 | 12 587 | 43 | 43 | 0.3 | 0.6 | 0.7 | 1.1 | |||
| Gallbladder | 11 469 | 6052 | 5417 | 20 | 21 | 18 | 0.3 | 0.3 | 0.2 | 0.7 | 1.0 |
| Oesophagus | 7836 | 6084 | 1752 | 14 | 21 | 6 | 0.2 | 0.3 | 0.1 | 2.6 | 2.9 |
Cancer types with a prevalence of ≥10 per 100 000 are presented, sorted by the number of prevalent cases. The definition of the cancer entities is reported in Toffolutti et al.10